Annual SG&A:
$266.13M+$52.24M(+24.42%)Summary
- As of today, BCRX annual SG&A is $266.13 million, with the most recent change of +$52.24 million (+24.42%) on December 31, 2024.
- During the last 3 years, BCRX annual SG&A has risen by +$147.31 million (+123.98%).
- BCRX annual SG&A is now at all-time high.
Performance
BCRX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$87.38M(-100.00%)Summary
- As of today, BCRX quarterly SG&A is $0.00, with the most recent change of -$87.38 million (-100.00%) on September 30, 2025.
- Over the past year, BCRX quarterly SG&A has dropped by -$65.08 million (-100.00%).
- BCRX quarterly SG&A is now -100.00% below its all-time high of $87.38 million, reached on June 30, 2025.
Performance
BCRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$7.06B-$8.78M(-0.12%)Summary
- As of today, BCRX TTM SG&A is -$7.06 billion, with the most recent change of -$8.78 million (-0.12%) on September 30, 2025.
- Over the past year, BCRX TTM SG&A has dropped by -$7.31 billion (-2922.30%).
- BCRX TTM SG&A is now -43732.27% below its all-time high of -$16.10 million.
Performance
BCRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
BCRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +24.4% | -100.0% | -2922.3% |
| 3Y3 Years | +124.0% | -100.0% | -4980.2% |
| 5Y5 Years | +616.9% | -100.0% | -10000.0% |
BCRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +124.0% | -100.0% | at low | -35.4% | at low |
| 5Y | 5-Year | at high | +616.9% | -100.0% | at low | -96.1% | at low |
| All-Time | All-Time | at high | >+9999.0% | -100.0% | at low | >-9999.0% | at low |
BCRX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $250.32M(-20.6%) |
| Jun 2025 | - | $87.38M(+6.0%) | $315.41M(+9.0%) |
| Mar 2025 | - | $82.47M(+2.5%) | $289.24M(+8.7%) |
| Dec 2024 | $266.13M(+24.4%) | $80.47M(+23.6%) | $266.13M(+6.4%) |
| Sep 2024 | - | $65.08M(+6.3%) | $250.04M(+6.1%) |
| Jun 2024 | - | $61.21M(+3.1%) | $235.61M(+4.5%) |
| Mar 2024 | - | $59.36M(-7.8%) | $225.39M(+5.4%) |
| Dec 2023 | $213.89M(+34.2%) | $64.38M(+27.1%) | $213.89M(+7.1%) |
| Sep 2023 | - | $50.65M(-0.7%) | $199.66M(+7.4%) |
| Jun 2023 | - | $51.00M(+6.5%) | $185.94M(+7.5%) |
| Mar 2023 | - | $47.87M(-4.6%) | $172.96M(+8.5%) |
| Dec 2022 | $159.37M(+34.1%) | $50.15M(+35.8%) | $159.37M(+10.2%) |
| Sep 2022 | - | $36.92M(-2.9%) | $144.60M(+1.4%) |
| Jun 2022 | - | $38.02M(+10.9%) | $142.68M(+8.9%) |
| Mar 2022 | - | $34.28M(-3.1%) | $130.99M(+10.2%) |
| Dec 2021 | $118.82M(+74.9%) | $35.39M(+1.1%) | $118.82M(+13.8%) |
| Sep 2021 | - | $34.99M(+32.9%) | $104.42M(+20.5%) |
| Jun 2021 | - | $26.32M(+19.0%) | $86.62M(+16.8%) |
| Mar 2021 | - | $22.11M(+5.4%) | $74.18M(+9.2%) |
| Dec 2020 | $67.93M(+83.0%) | $20.99M(+22.0%) | $67.93M(+18.3%) |
| Sep 2020 | - | $17.20M(+23.9%) | $57.43M(+10.5%) |
| Jun 2020 | - | $13.88M(-12.5%) | $51.97M(+11.2%) |
| Mar 2020 | - | $15.87M(+51.3%) | $46.75M(+25.9%) |
| Dec 2019 | $37.12M(+25.8%) | $10.49M(-10.6%) | $37.12M(+19.3%) |
| Sep 2019 | - | $11.73M(+35.5%) | $31.12M(+14.0%) |
| Jun 2019 | - | $8.66M(+38.8%) | $27.31M(-3.0%) |
| Mar 2019 | - | $6.24M(+38.9%) | $28.14M(-4.6%) |
| Dec 2018 | $29.51M(+111.8%) | $4.49M(-43.3%) | $29.51M(-0.7%) |
| Sep 2018 | - | $7.92M(-16.5%) | $29.72M(+18.2%) |
| Jun 2018 | - | $9.49M(+24.7%) | $25.14M(+36.0%) |
| Mar 2018 | - | $7.61M(+62.0%) | $18.48M(+32.7%) |
| Dec 2017 | $13.93M(+23.8%) | $4.70M(+40.5%) | $13.93M(+18.1%) |
| Sep 2017 | - | $3.34M(+18.0%) | $11.80M(+5.2%) |
| Jun 2017 | - | $2.83M(-7.3%) | $11.21M(+1.0%) |
| Mar 2017 | - | $3.06M(+19.4%) | $11.10M(-1.4%) |
| Dec 2016 | $11.25M(-13.8%) | $2.56M(-7.1%) | $11.25M(+29.5%) |
| Sep 2016 | - | $2.76M(+1.2%) | $8.69M(+0.3%) |
| Jun 2016 | - | $2.72M(-15.2%) | $8.67M(-8.5%) |
| Mar 2016 | - | $3.21M(>+9900.0%) | $9.48M(-8.2%) |
| Dec 2015 | $13.05M(+74.9%) | $0.00(-100.0%) | $10.33M(-16.6%) |
| Sep 2015 | - | $2.73M(-22.7%) | $12.37M(+8.0%) |
| Jun 2015 | - | $3.53M(-13.0%) | $11.46M(+15.3%) |
| Mar 2015 | - | $4.06M(+98.3%) | $9.93M(+33.1%) |
| Dec 2014 | $7.46M(+24.2%) | $2.05M(+13.0%) | $7.46M(+11.6%) |
| Sep 2014 | - | $1.81M(-10.0%) | $6.68M(+7.7%) |
| Jun 2014 | - | $2.01M(+26.8%) | $6.21M(+14.4%) |
| Mar 2014 | - | $1.59M(+25.0%) | $5.43M(+3.9%) |
| Dec 2013 | $6.01M(-34.2%) | $1.27M(-5.0%) | $5.22M(-11.2%) |
| Sep 2013 | - | $1.34M(+8.6%) | $5.88M(-4.1%) |
| Jun 2013 | - | $1.23M(-10.9%) | $6.13M(-5.8%) |
| Mar 2013 | - | $1.38M(-28.4%) | $6.51M(-5.8%) |
| Dec 2012 | $9.13M(-23.8%) | $1.93M(+21.2%) | $6.91M(+14.5%) |
| Sep 2012 | - | $1.59M(-1.1%) | $6.04M(-21.9%) |
| Jun 2012 | - | $1.61M(-9.7%) | $7.73M(-23.7%) |
| Mar 2012 | - | $1.78M(+68.8%) | $10.12M(-18.0%) |
| Dec 2011 | $11.98M(+2.2%) | $1.05M(-67.9%) | $12.34M(-15.9%) |
| Sep 2011 | - | $3.28M(-18.0%) | $14.67M(-3.4%) |
| Jun 2011 | - | $4.00M(+0.0%) | $15.18M(+5.5%) |
| Mar 2011 | - | $4.00M(+18.4%) | $14.38M(+1.4%) |
| Dec 2010 | $11.72M(+2.1%) | $3.38M(-10.9%) | $14.18M(-1.8%) |
| Sep 2010 | - | $3.79M(+18.2%) | $14.45M(+5.3%) |
| Jun 2010 | - | $3.21M(-15.5%) | $13.72M(+7.0%) |
| Mar 2010 | - | $3.80M(+4.1%) | $12.82M(+15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $11.48M(+10.4%) | $3.65M(+19.0%) | $11.07M(+13.0%) |
| Sep 2009 | - | $3.06M(+32.5%) | $9.80M(+11.4%) |
| Jun 2009 | - | $2.31M(+13.0%) | $8.80M(+0.4%) |
| Mar 2009 | - | $2.05M(-13.8%) | $8.77M(-5.1%) |
| Dec 2008 | $10.40M(+9.9%) | $2.38M(+15.1%) | $9.24M(-1.2%) |
| Sep 2008 | - | $2.06M(-9.6%) | $9.35M(-5.4%) |
| Jun 2008 | - | $2.28M(-9.2%) | $9.88M(+2.8%) |
| Mar 2008 | - | $2.51M(+1.1%) | $9.61M(+1.5%) |
| Dec 2007 | $9.47M(+55.0%) | $2.49M(-4.2%) | $9.47M(+9.9%) |
| Sep 2007 | - | $2.60M(+28.9%) | $8.61M(+13.1%) |
| Jun 2007 | - | $2.01M(-15.1%) | $7.62M(+9.0%) |
| Mar 2007 | - | $2.37M(+45.4%) | $6.99M(+14.4%) |
| Dec 2006 | $6.11M(+65.7%) | $1.63M(+2.0%) | $6.11M(+2.7%) |
| Sep 2006 | - | $1.60M(+15.5%) | $5.95M(+15.6%) |
| Jun 2006 | - | $1.38M(-7.4%) | $5.14M(+14.6%) |
| Mar 2006 | - | $1.50M(+1.8%) | $4.49M(+21.7%) |
| Dec 2005 | $3.69M(+14.5%) | $1.47M(+84.8%) | $3.69M(+18.4%) |
| Sep 2005 | - | $795.00K(+9.4%) | $3.11M(+2.2%) |
| Jun 2005 | - | $727.00K(+4.5%) | $3.05M(-6.1%) |
| Mar 2005 | - | $696.00K(-22.3%) | $3.25M(+1.1%) |
| Dec 2004 | $3.22M(+14.6%) | $896.00K(+23.1%) | $3.21M(-6.7%) |
| Sep 2004 | - | $728.00K(-21.4%) | $3.44M(+6.2%) |
| Jun 2004 | - | $926.00K(+40.3%) | $3.24M(+13.0%) |
| Mar 2004 | - | $660.00K(-41.3%) | $2.86M(+1.9%) |
| Dec 2003 | $2.81M(-1.5%) | $1.13M(+113.9%) | $2.81M(+25.2%) |
| Sep 2003 | - | $526.00K(-4.9%) | $2.25M(-5.4%) |
| Jun 2003 | - | $553.00K(-8.9%) | $2.38M(-11.8%) |
| Mar 2003 | - | $607.00K(+8.4%) | $2.69M(-5.6%) |
| Dec 2002 | $2.86M(-6.4%) | $560.00K(-14.5%) | $2.85M(+24.4%) |
| Sep 2002 | - | $655.00K(-24.8%) | $2.29M(-1.5%) |
| Jun 2002 | - | $871.00K(+13.4%) | $2.33M(+10.1%) |
| Mar 2002 | - | $768.00K(>+9900.0%) | $2.11M(+3.4%) |
| Dec 2001 | $3.05M(-14.2%) | $0.00(-100.0%) | $2.04M(0.0%) |
| Sep 2001 | - | $689.00K(+4.9%) | $2.04M(+50.8%) |
| Jun 2001 | - | $657.00K(-6.0%) | $1.36M(+94.0%) |
| Mar 2001 | - | $699.00K(>+9900.0%) | $699.00K(>+9900.0%) |
| Dec 2000 | $3.56M(+22.7%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1999 | $2.90M(-6.5%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1998 | $3.10M(+14.8%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 1998 | - | $0.00(0.0%) | $600.00K(-45.5%) |
| Jun 1998 | - | $0.00(0.0%) | $1.10M(-47.6%) |
| Mar 1998 | - | $0.00(-100.0%) | $2.10M(-25.0%) |
| Dec 1997 | $2.70M(0.0%) | $600.00K(+20.0%) | $2.80M(0.0%) |
| Sep 1997 | - | $500.00K(-50.0%) | $2.80M(0.0%) |
| Jun 1997 | - | $1.00M(+42.9%) | $2.80M(-3.4%) |
| Mar 1997 | - | $700.00K(+16.7%) | $2.90M(+7.4%) |
| Dec 1996 | $2.70M(+22.7%) | $600.00K(+20.0%) | $2.70M(-3.6%) |
| Sep 1996 | - | $500.00K(-54.5%) | $2.80M(0.0%) |
| Jun 1996 | - | $1.10M(+120.0%) | $2.80M(+27.3%) |
| Mar 1996 | - | $500.00K(-28.6%) | $2.20M(-4.3%) |
| Dec 1995 | $2.20M(+15.8%) | $700.00K(+40.0%) | $2.30M(+15.0%) |
| Sep 1995 | - | $500.00K(0.0%) | $2.00M(+5.3%) |
| Jun 1995 | - | $500.00K(-16.7%) | $1.90M(-5.0%) |
| Mar 1995 | - | $600.00K(+50.0%) | $2.00M(+5.3%) |
| Dec 1994 | $1.90M | $400.00K(0.0%) | $1.90M(+26.7%) |
| Sep 1994 | - | $400.00K(-33.3%) | $1.50M(+36.4%) |
| Jun 1994 | - | $600.00K(+20.0%) | $1.10M(+120.0%) |
| Mar 1994 | - | $500.00K | $500.00K |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual SG&A?
- What is the all-time high annual SG&A for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual SG&A year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM SG&A year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual SG&A?
The current annual SG&A of BCRX is $266.13M
What is the all-time high annual SG&A for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual SG&A is $266.13M
What is BioCryst Pharmaceuticals, Inc. annual SG&A year-on-year change?
Over the past year, BCRX annual SG&A has changed by +$52.24M (+24.42%)
What is BioCryst Pharmaceuticals, Inc. quarterly SG&A?
The current quarterly SG&A of BCRX is $0.00
What is the all-time high quarterly SG&A for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly SG&A is $87.38M
What is BioCryst Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
Over the past year, BCRX quarterly SG&A has changed by -$65.08M (-100.00%)
What is BioCryst Pharmaceuticals, Inc. TTM SG&A?
The current TTM SG&A of BCRX is -$7.06B
What is the all-time high TTM SG&A for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM SG&A is -$16.10M
What is BioCryst Pharmaceuticals, Inc. TTM SG&A year-on-year change?
Over the past year, BCRX TTM SG&A has changed by -$7.31B (-2922.30%)